TINA KEENER: Open Payments
NPI 1164990958 · UNIONTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$222 in 10 payments from 8 companies in 2025. Trend: 2023 $947 · 2024 $1,813 · 2025 $222
Food & beverage: $222
| Company | Payments | Amount |
|---|---|---|
| Organogenesis Inc. | 2 | $55 |
| ABBVIE INC. | 2 | $47 |
| Smith+Nephew, Inc. | 1 | $34 |
| Abbott Laboratories | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
| Tandem Diabetes Care, Inc. | 1 | $14 |
Products named: AFFINITY, VRAYLAR, RENASYS GO v2 HOME, FREESTYLE LIBRE 3, TRELEGY ELLIPTA, FANAPT, XIFAXAN, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across PA — which companies pay providers there.
